Premium
Maternal cytomegalovirus sero‐positivity and autism symptoms in children
Author(s) -
Slawinski Brooke L.,
Talge Nicole,
Ingersoll Brooke,
Smith Arianna,
Glazier Alicynne,
Kerver Jean,
Paneth Nigel,
Racicot Karen
Publication year - 2018
Publication title -
american journal of reproductive immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.071
H-Index - 97
eISSN - 1600-0897
pISSN - 1046-7408
DOI - 10.1111/aji.12840
Subject(s) - serostatus , cytomegalovirus , autism , medicine , herpes simplex virus , autism spectrum disorder , population , immunology , asymptomatic , pediatrics , herpesviridae , virus , psychiatry , viral disease , viral load , environmental health
Problem Autism spectrum disorder ( ASD ) is one of the most commonly diagnosed neurodevelopmental disorders in the United States. While ASD can be significantly influenced by genetics, prenatal exposure to maternal infections has also been implicated in conferring risk. Despite this, the effects of several important maternal pathogens, such as cytomegalovirus ( CMV ) and herpes simplex virus 2 ( HSV 2), remain unknown. Method of study We tested whether maternal CMV and/or HSV 2 sero‐positivity was associated with ASD symptoms in children. ELISA was used to assay for CMV IgG and HSV 2 IgG in serum from the mothers of 82 children whose ASD symptoms were assessed at 3‐6 years of age using the Social Responsiveness Scale version 2 ( SRS ‐2). Results Associations between maternal viral serostatus and SRS ‐2 scores were estimated using linear regression with covariate adjustments. The children of mothers sero‐positive for CMV , but not for HSV 2, had SRS ‐2 scores 3.6‐4.2 points higher, depending on the adjustment model, than sero‐negative women, a significant finding, robust to several statistical adjustments. Conclusion Our results suggest that maternal CMV infections may influence ASD symptoms. These findings are being further evaluated in ongoing prospective studies with larger population samples.